Go Pro
→ Trump’s New Currency Reset (From Porter & Company) (Ad)tc pixel Free CRON Stock Alerts

Cronos Group (CRON) Competitors

Cronos Group logo
C$4.31 -0.10 (-2.27%)
As of 01:59 PM Eastern
Compare

CRON vs. APHA, BHC, MJN, CARA, and THCX

Should you buy Cronos Group stock or one of its competitors? Cronos Group's main competitors and comparable companies include Aphria (APHA), Bausch Health Companies (BHC), Cronos Group (MJN), Cara Operations (CARA), and Hydropothecary (THCX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Cronos Group compare to Aphria?

Aphria (TSE:APHA) and Cronos Group (TSE:CRON) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Cronos Group has a net margin of 38.95% compared to Aphria's net margin of 0.00%. Cronos Group's return on equity of 6.46% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Cronos Group 38.95%6.46%-3.73%

4.4% of Cronos Group shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cronos Group has lower revenue, but higher earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A
Cronos GroupC$179.09M8.87-C$32.78MC$0.1922.68

Cronos Group has a consensus target price of C$4.92, suggesting a potential upside of 14.08%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Aphria.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Cronos Group had 2 more articles in the media than Aphria. MarketBeat recorded 2 mentions for Cronos Group and 0 mentions for Aphria. Cronos Group's average media sentiment score of 0.47 beat Aphria's score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media.

Company Overall Sentiment
Aphria Neutral
Cronos Group Neutral

Summary

Cronos Group beats Aphria on 12 of the 14 factors compared between the two stocks.

How does Cronos Group compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Cronos Group (TSE:CRON) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations and valuation.

Bausch Health Companies has a beta of 0.959729, suggesting that its share price is 4% less volatile than the broader market. Comparatively, Cronos Group has a beta of 1.13355, suggesting that its share price is 13% more volatile than the broader market.

10.6% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 4.4% of Cronos Group shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Comparatively, 46.4% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cronos Group has a net margin of 38.95% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch Health Companies-12.02% 87.57% 4.16%
Cronos Group 38.95%6.46%-3.73%

Cronos Group has lower revenue, but higher earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch Health CompaniesC$10.85B0.31-C$125.65M-C$2.94N/A
Cronos GroupC$179.09M8.87-C$32.78MC$0.1922.68

Cronos Group has a consensus price target of C$4.92, indicating a potential upside of 14.08%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch Health Companies
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Bausch Health Companies and Bausch Health Companies both had 2 articles in the media. Cronos Group's average media sentiment score of 0.47 beat Bausch Health Companies' score of 0.13 indicating that Cronos Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch Health Companies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cronos Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Cronos Group beats Bausch Health Companies on 11 of the 15 factors compared between the two stocks.

How does Cronos Group compare to Cronos Group?

Cronos Group (CVE:MJN) and Cronos Group (TSE:CRON) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

In the previous week, Cronos Group had 1 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for Cronos Group and 1 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.67 beat Cronos Group's score of 0.47 indicating that Cronos Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cronos Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Cronos Group has a consensus price target of C$4.92, indicating a potential upside of 14.08%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Cronos Group has higher earnings, but lower revenue than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupN/AN/AN/AN/AN/A
Cronos GroupC$179.09M8.87-C$32.78MC$0.1922.68

Cronos Group has a net margin of 38.95% compared to Cronos Group's net margin of 0.00%. Cronos Group's return on equity of 6.46% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos GroupN/A N/A N/A
Cronos Group 38.95%6.46%-3.73%

4.4% of Cronos Group shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Cronos Group beats Cronos Group on 9 of the 11 factors compared between the two stocks.

How does Cronos Group compare to Cara Operations?

Cara Operations (TSE:CARA) and Cronos Group (TSE:CRON) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

4.4% of Cronos Group shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cronos Group has a net margin of 38.95% compared to Cara Operations' net margin of 0.00%. Cronos Group's return on equity of 6.46% beat Cara Operations' return on equity.

Company Net Margins Return on Equity Return on Assets
Cara OperationsN/A N/A N/A
Cronos Group 38.95%6.46%-3.73%

In the previous week, Cronos Group had 2 more articles in the media than Cara Operations. MarketBeat recorded 2 mentions for Cronos Group and 0 mentions for Cara Operations. Cronos Group's average media sentiment score of 0.47 beat Cara Operations' score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media.

Company Overall Sentiment
Cara Operations Neutral
Cronos Group Neutral

Cronos Group has a consensus price target of C$4.92, indicating a potential upside of 14.08%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts clearly believe Cronos Group is more favorable than Cara Operations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cara Operations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Cara Operations has higher earnings, but lower revenue than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cara OperationsN/AN/AN/AN/AN/A
Cronos GroupC$179.09M8.87-C$32.78MC$0.1922.68

Summary

Cronos Group beats Cara Operations on 10 of the 11 factors compared between the two stocks.

How does Cronos Group compare to Hydropothecary?

Hydropothecary (CVE:THCX) and Cronos Group (TSE:CRON) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

In the previous week, Cronos Group had 2 more articles in the media than Hydropothecary. MarketBeat recorded 2 mentions for Cronos Group and 0 mentions for Hydropothecary. Cronos Group's average media sentiment score of 0.47 beat Hydropothecary's score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media.

Company Overall Sentiment
Hydropothecary Neutral
Cronos Group Neutral

Hydropothecary has higher earnings, but lower revenue than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HydropothecaryN/AN/AN/AN/AN/A
Cronos GroupC$179.09M8.87-C$32.78MC$0.1922.68

4.4% of Cronos Group shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cronos Group has a net margin of 38.95% compared to Hydropothecary's net margin of 0.00%. Cronos Group's return on equity of 6.46% beat Hydropothecary's return on equity.

Company Net Margins Return on Equity Return on Assets
HydropothecaryN/A N/A N/A
Cronos Group 38.95%6.46%-3.73%

Cronos Group has a consensus price target of C$4.92, suggesting a potential upside of 14.08%. Given Cronos Group's stronger consensus rating and higher probable upside, analysts plainly believe Cronos Group is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Cronos Group beats Hydropothecary on 10 of the 11 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRON vs. The Competition

Export
MetricCronos GroupPharmaceuticals IndustryHealthcare SectorTSE Exchange
Market CapC$1.59BC$11.73BC$6.98BC$12.55B
Dividend YieldN/A2.70%2.58%6.20%
P/E Ratio22.68781.45269.2730.72
Price / Sales8.87748.18597.129.75
Price / Cash1.6767.4570.5382.29
Price / Book1.4410.7313.064.64
Net Income-C$32.78MC$2.77BC$3.45BC$299.09M
7 Day Performance-0.23%-0.11%0.91%0.91%
1 Month Performance10.80%0.06%1.59%3.88%
1 Year Performance24.21%161.21%67.34%36.14%

Cronos Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRON
Cronos Group
2.9829 of 5 stars		C$4.31
-2.3%		C$4.92
+14.1%		+21.8%C$1.59BC$179.09M22.68450
APHA
Aphria
N/AN/AN/AN/AC$5.24BC$611.06MN/A1,200
BHC
Bausch Health Companies
0.6014 of 5 stars		C$8.28
-5.9%		N/A-10.5%C$3.10BC$10.85BN/A19,900
MJN
Cronos Group
N/AC$12.15
-1.9%		N/A+0.0%C$1.73BN/AN/A7,600
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/AN/A80

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:CRON) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Central banks bought 710 tonnes - this fund pays monthly
Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Gold buyout deals have handed shareholders overnight gains up to 79 percent
Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...
Golden Portfolio | Sponsoredtc pixel
Who Really Gets Rich from IPOs?
Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...
Weiss Ratings | Sponsoredtc pixel
How a rare metal shortage sent gains up 2512 percent
In 2010, a rare earth metal called dysprosium surged 2,512 percent in two and a half years after China cut exp...
Awesomely | Sponsoredtc pixel
$100 for this… $500 for that. Here’s how to stop the bleeding today
Rising costs are squeezing households nationwide. USA Today reports more families are moving in together, whil...
Brownstone Research | Sponsoredtc pixel